AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Business/Medical Editors
PLEASANTON & FOSTER CITY, Calif.--(BW HealthWire)--July 27, 2000
Roche and PE Biosystems Group (NYSE:PEB), a PE Corporation business now conducting business under the Applied Biosystems name, today announced they have signed an agreement to expand the markets each company serves with products incorporating the polymerase chain reaction (PCR) technology.
This new arrangement will allow both companies to develop and market products for all potential uses of PCR. Additionally, Applied Biosystems will continue to distribute products Roche manufactures for research and non-diagnostic applications.
It is expected that the new agreement could further accelerate the…
Source: HighBeam Research, Roche and PE Biosystems Expand Markets Served With PCR Products.